Hypoxic microenvironment promotes up-regulation of hypoxia inducible factor-1 alpha, bFGF, and VEGF, while combined with lenvatinib inhibits the activity of tumor angiogenesis factors (18, 37). This evidence concerns the gene FGF2 and neoplasm.